The Role of Aspirin Today Our Good Old Friend Aspirin Earlier Primary Prevention Trials Aspirin Favored for Serious Vascular Events Physicians Health Study Contemporary Aspirin Clinical Trials ID: 775086
Download Presentation The PPT/PDF document " Aspirin in Cardioprevention:" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Aspirin in Cardioprevention:
Slide2Slide3The Role of Aspirin Today
Slide4Our Good Old Friend Aspirin
Slide5Earlier Primary Prevention Trials: Aspirin Favored for Serious Vascular Events
Slide6Physicians' Health Study
Slide7Contemporary Aspirin Clinical Trialsfor Primary Prevention
Slide8Risk Factors for Primary CVD Prevention
Slide9USPSTF 2016 Statement of Aspirin Use
Slide10Aspirin Pharmacology and Biological Effect
Slide11ARRIVE Study Design
Slide12ARRIVE Patient Enrollment Criteria
Slide13ARRIVE Results
Slide14ARRIVE Results (cont)
Slide15Primary Prevention Trials With Aspirin in Diabetic Patients
Slide16ASCEND Study Design
Slide17ASCEND Results
Slide18Platelet Activity in Diabetic Patients and the Potential Role of Aspirin
Slide19Aspirin Recommendations for Diabetic Patients
Slide20Bleeding Is Not New News
Slide21COMPASS Trial
Slide22COGENT Trial: Optimization of GI Events
Slide23Existing Treatment Strategies for Prevention of MACE
Slide24What Do These New Trials Tell Us?
Slide25Regular Aspirin Use and Cancer Risk
Slide26Duration of Aspirin Use and CRC Risk
Slide27ASPREE Study Design
Slide28ADAPTABLE Study Design
Slide29Conclusion
Slide30